| Trazodone Hydrochloride Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Trazodone Hydrochloride 100 mg | tablet | oral | 1.0 each | OTC |
| Trazodone Hydrochloride 150 mg | tablet | oral | 1.0 each | OTC |
| Trazodone Hydrochloride 50 mg | tablet | oral | 1.0 each | OTC |
| Trazodone Hydrochloride 300 mg | tablet | oral | 1.0 each | OTC |
| Trazodone Hydrochloride - | powder | compounding | 100.0 gram(s) | OTC |
Posted by tinac62 7 months ago
I am prescribed trazodone 150mg cause I am a sever clinical depressant. I have adjusted it to 75mg. due to feeling so bad on...
Posted by des115 about 1 year ago
I was given a prescription for Trazodone four days ago beginning with a 150mg dose. I have a very long history of getting by...
Posted by tonybaysf about 1 year ago
I've only taken Trazoodone on rare occasion, I'v ehad terrible nightmares. That's why I am so leary to tak ethe drug, it's ...
Lower Bone Mineral Density Found in Older Men Using SSRIs - Medscape (subscription)
... with lower mean BMD at the hip and spine, but there was no significant difference among users of TCAs or trazodone hydrochloride and nonusers. Table. ...
Fri Jul 06 12:36:09 -0400 2007
Lower Bone Mineral Density Found in Older Men Using SSRIs - Medscape (subscription)
... with lower mean BMD at the hip and spine, but there was no significant difference among users of TCAs or trazodone hydrochloride and nonusers. Table. ...
Fri Jul 06 12:36:09 -0400 2007
Association of Low Bone Mineral Density With Selective Serotonin ... - Archives of Internal Medicine
There was no significant difference among users of trazodone hydrochloride (n = 52) or tricyclic antidepressants (n = 99) compared with nonusers. ...
Mon Jun 25 13:07:15 -0400 2007
trazodone hydrochloride - The hydrochloride salt form of trazodone, a synthetic triazolopyridine derivative with antidepressant and sedative properties. Based on studies from animal models, trazodone selectively inhibits the re-uptake of serotonin by synaptosomes in the brain, thereby increasing serotonin levels in the synaptic cleft and potentiating serotonin activity. Trazodone is not a monoamine oxidase inhibitor and, unlike amphetamine-type drugs, does not stimulate the central nervous system. The sedative effect of trazodone is likely via alpha-adrenergic and mild histamine H1 blocking actions.